TY - JOUR
T1 - Hepatic repopulation with stably transduced conditionally immortalized hepatocytes in the Gunn rat
AU - Kawashita, Yujo
AU - Guha, Chandan
AU - Moitra, Rituparna
AU - Wang, Xia
AU - Fox, Ira J.
AU - Roy-Chowdhury, Jayanta
AU - Roy-Chowdhury, Namita
N1 - Funding Information:
This work was supported in part by NIH Grants 5-RO1 DK 039137-16 (to N.R.C.), 5 RO1 DK 46057-13 (to J.R.C.), 1 R01 DK064670 (to C.G.), R01 AI49472 and RO1 DK48794 (to I.J.F.). Liver Pathobiology and Gene Therapy Research Center (5 P30 DK41296-17) and the Gene Therapy Core of Albert Einstein College of Medicine.
PY - 2008/7
Y1 - 2008/7
N2 - Background/Aims: Conditionally immortalized hepatocytes offer a renewable source of hepatocytes, but although preparative maneuvers have been developed for hepatic repopulation with primary hepatocytes, extensive proliferation of transplanted immortalized hepatocytes has not been accomplished heretofore. Our aim was to achieve ex vivo gene therapy of uridinediphosphoglucuronate glucuronosyltransferase-1A1 (UGT1A1)-deficient jaundiced Gunn rats (model of Crigler-Najjar syndrome type-1) by hepatic repopulation with genetically modified and conditionally immortalized hepatocytes. Methods: Gunn rat hepatocytes were conditionally immortalized by stable transduction with a thermolabile mutant simian virus 40 T-antigen (tsTagA58) and further transduced with UGT1A1. These hepatocytes proliferate at 33°C, but at 37°C the tsTagA58 is degraded and the cells become quiescent. The cells were transplanted into Gunn rat livers after preparative hepatic irradiation (50 Gy) and 66% hepatectomy. Results: The engrafted UGT1A1-positive immortalized hepatocytes replaced ∼80% of the host hepatocytes in 20 weeks, leading to normalization of hyperbilirubinemia. Liver histology, and serum albumin and alanine aminotransferase levels remained normal. Conclusions: We achieved complete cure of hyperbilirubinemia in Gunn rats by ex vivo gene therapy via genetically modified and conditionally immortalized hepatocytes.
AB - Background/Aims: Conditionally immortalized hepatocytes offer a renewable source of hepatocytes, but although preparative maneuvers have been developed for hepatic repopulation with primary hepatocytes, extensive proliferation of transplanted immortalized hepatocytes has not been accomplished heretofore. Our aim was to achieve ex vivo gene therapy of uridinediphosphoglucuronate glucuronosyltransferase-1A1 (UGT1A1)-deficient jaundiced Gunn rats (model of Crigler-Najjar syndrome type-1) by hepatic repopulation with genetically modified and conditionally immortalized hepatocytes. Methods: Gunn rat hepatocytes were conditionally immortalized by stable transduction with a thermolabile mutant simian virus 40 T-antigen (tsTagA58) and further transduced with UGT1A1. These hepatocytes proliferate at 33°C, but at 37°C the tsTagA58 is degraded and the cells become quiescent. The cells were transplanted into Gunn rat livers after preparative hepatic irradiation (50 Gy) and 66% hepatectomy. Results: The engrafted UGT1A1-positive immortalized hepatocytes replaced ∼80% of the host hepatocytes in 20 weeks, leading to normalization of hyperbilirubinemia. Liver histology, and serum albumin and alanine aminotransferase levels remained normal. Conclusions: We achieved complete cure of hyperbilirubinemia in Gunn rats by ex vivo gene therapy via genetically modified and conditionally immortalized hepatocytes.
KW - Crigler-Najjar syndrome
KW - Gene therapy
KW - Hepatic irradiation
KW - Hepatic repopulation
KW - Immortalized hepatocytes
UR - http://www.scopus.com/inward/record.url?scp=44649130604&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44649130604&partnerID=8YFLogxK
U2 - 10.1016/j.jhep.2008.02.020
DO - 10.1016/j.jhep.2008.02.020
M3 - Article
C2 - 18466997
AN - SCOPUS:44649130604
SN - 0168-8278
VL - 49
SP - 99
EP - 106
JO - Journal of Hepatology
JF - Journal of Hepatology
IS - 1
ER -